DNAnexus, Inc. announced that it has received $58 million in an equity round of funding led by new investor, Foresite Capital Management, LLC on January 2, 2017. The transaction also included participation from new investor, Microsoft Corporation (NasdaqGS:MSFT), and existing investors, TPG Biotech, WuXi NextCODE Genomics, Claremont Creek Ventures, MidCap Financial, LLC, and GV.